13G Filing: Iroquois Capital Management, LLC and Apricus Biosciences Inc. (APRI)

CUSIP No: 03832V307

Item 1.

(a)

Name of Issuer
Apricus Biosciences, Inc. (the “Company”)

(b)

Address of Issuer’s Principal Executive Offices
11975 El Camino Real, Suite 300, San Diego, CA 92130

Item 2 (a).

Name of Person Filing

Item 2 (b).

Address of Principal Business Office or, if none, Residence

Item 2 (c).

Citizenship

This Schedule 13G is being filed on behalf of (i) Iroquois Capital
Management L.L.C., a Delaware limited liability company (“Iroquois”), and (ii) Richard Abbe, an individual who is a
citizen of the United States of America (“Mr. Abbe,” together with Iroquois, the “Reporting Persons”).

The Reporting Persons have entered into a Joint Filing Agreement,
a copy of which is filed with this Schedule 13G as Exhibit 1, pursuant to which the Reporting Persons have agreed to file this
Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended.

The principal business office of all of the Reporting Persons
is 205 East 42nd Street, 20th Floor, New York, NY 10017.

Item 2 (d)

Title of Class of Securities
Common Stock, $.0001 par value per share

Item 2 (e)

CUSIP Number
03832V307

Item 3.

If this statement is filed pursuant to §§240.13d-1(b)
or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable.

(a)

o

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b)

o

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c)

o

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d)

o

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e)

o

An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

(f)

o

An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

(g)

o

A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

(h)

o

A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

o

A church plan that is excluded from the definition of an investment company under section

13G Filing: Iroquois Capital Management, LLC and Apricus Biosciences Inc. (APRI)

Published on June 19, 2017 at 3:03 pm by Insider Monkey Staff in Hedge Funds

Page 4 of 7 – SEC Filing

Follow Seelos Therapeutics Inc. (NASDAQ:SEEL)

Follow Seelos Therapeutics Inc. (NASDAQ:SEEL)

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Published on May 1, 2024 at by Inan Dogan, PhD

A New Dawn is Coming to U.S. Stocks

Published on May 2, 2024 at by Insider Monkey Staff